Delivery Order SPE2DB24D1104-SPE2DB25FYFJ5
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,215.76 to AmerisourceBergen Drug Corp for XEOMIN 50U (botulinum toxin Type A), a pharmaceutical product used in medical and therapeutic applications. This firm fixed price delivery order, issued on August 29, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, a botulinum toxin product commonly used in medical and cosmetic applications. This firm fixed-price delivery order, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive award to the incumbent vendor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,587.40 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitive award, issued on August 22, 2025, with an ultimate completion date of September 15, 2025, carries firm fixed pricing and represents a non-set-aside contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $3,352.44 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin-based therapeutic product commonly used for medical and cosmetic purposes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $16,762.20 to AmerisourceBergen Drug Corp for XEOMIN 200 Unit Vials, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on August 27, 2025, with an ultimate completion date of September 18, 2025, was competitively awarded without set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. As a leading pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,039.40 to AmerisourceBergen Drug Corp for 50-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic applications. This $10,057.32 firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by September 22, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,352.16 to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic applications within military and federal healthcare systems. The contract, awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, carries a firm fixed price and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic purposes, valued at $8,381.10. Issued on August 18, 2025, with an ultimate completion date of September 9, 2025, this firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $1,676.22 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product commonly used for therapeutic and cosmetic medical applications. This firm fixed-price delivery order, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award was made through open competition with no set-aside...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFJ5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,352.44 to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin product used for medical purposes. This firm fixed price delivery order, issued on September 4, 2025, with an ultimate completion date of September 25, 2025, represents a non-competed award under the company's existing contract vehicle with the DLA. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support is advancing toward establishing Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen to continue serving Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/4/25 |